Use of a pyrazole derivative for preparing medicines useful for treating renal diseases
AssigneeSanofi-Aventis
InventorsMohammed Bensaid, Jean-Marc Herbert, Philip Janiak
Life of this patent
Estimating the term…
Abstract
This invention relates to use of a pyrazole-derived compound that is an antagonist of cannabinoid CB1 receptors, alone or in combination with another active ingredient, for preparing medicinal products that are of use in the prevention and treatment of kidney diseases.
Claims24
A method for the treatment of a kidney disease selected from the group consisting of chronic renal failure, terminal kidney disease, renal hypertrophy, renal hyperplasia, and glomerulose nephritis, comprising administering to a patient in need of said treatment a therapeutically effective amount of a compound that is an antagonist for cannabinoid CB1receptor, which is chosen from rimonabant and N-piperidino-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethylpyrazole-3-carboxamide.
Dependencies are inferred from the claim text.